If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNuformix Share News (NFX)

Share Price Information for Nuformix (NFX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.185
Bid: 0.17
Ask: 0.20
Change: 0.00 (0.00%)
Spread: 0.03 (17.647%)
Open: 0.185
High: 0.00
Low: 0.00
Prev. Close: 0.185
NFX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Neometals swings to loss; Funding Circle strikes deal

Fri, 23rd Sep 2022 21:02

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

Caretech Holdings PLC - Hertfordshire, England-based residential social care and education services - Says the High Court of Justice in England and Wales has sanctioned the takeover from Amalfi Bidco Ltd, a consortium which includes CareTech founders Farouq and Haroon Sheikh and THCP Advisory Ltd. Confirms that September 26 will be the last day of dealings in, and for the registration of transfers of, and disablement of its shares.

----------

Tirupati Graphite PLC - graphite and graphene mining and processing in Madagascar - Says its Vatomina preconcentrate plant in Madagascar has achieved a name plate ore feed capacity of 600 tons per day. Expects to have a net ore throughput capacity of 2,400 tons per day and a name plate capacity of 36,000 tpa flake graphite production per annum across the Sahamamy and Vatomina projects. Development of the balance of 54,000 tons planned capacity across existing Madagascan projects will follow targeting the end of 2024 for completion.

"This progress will help us to achieve our long-term goal of producing circa 8% of the global flake graphite market or 400,000 tpa by 2030," Executive Chair Shishir Podda says.

----------

Nuformix PLC - London-based pharmaceutical firm targeting fibrosis and oncology - Says NXP002, a potential treatment for idiopathic pulmonary fibrosis, appeared well tolerated in very high doses in a pre-clinical update. Says it currently continues to be "challenging" to achieve consistent and reproducible results, which will likely increase in the study of combination therapies. Stops its current study and will initiate studies in 3D human IPF lung tissue using a disease and species relevant model, as a consequence.

----------

Manolete Partners PLC - London-based insolvency litigation financing - Says it was granted permission by the Court of Appeal to appeal a decision in the High Court. Warns that the process is likely to take some months and the outcome cannot be guaranteed.

----------

Anglo Pacific Group PLC - London-based natural resources royalty company - Says it has a 2.0% net smelter royalty interest over the West Musgrave project. Says first production for the project is targeted for the second half 2025.

----------

Funding Circle Holdings PLC - London-based commercial lender - Enters a lending partnership with Bayview Asset Management to provide GBP700 million of funding to small businesses over an 18-month period. This takes the total new forward flow funding commitments leveraging its platform to GBP2.4 billion.

----------

Neometals Ltd - London-based battery materials from upstream extraction and downstream processing - Swings to a pretax loss of USD16.2 million in the year which ends June 30 from a profit of USD21.0 million the year before, as other income falls to USD912,857 from USD35.8 million. Cites Covid-19 headwinds disrupting its international engagements and European business development focus.

----------

Rockhopper Exploration PLC - Salisbury, England-based oil & gas exploration and production company - Says the transaction which allowed Harbour Energy PLC to exit and Navitas Petroleum LPto enter the North Falkland Basin with a 65% stake in, and operatorship of, all of its North Falkland Basin licences has been completed.

----------

By Abby Amoakuh; abbyamoakuh@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
25 Oct 2019 12:27

Nuformix Confirms Japan, Asia Licencing Talks As Shares Surge

Nuformix Confirms Japan, Asia Licencing Talks As Shares Surge

Read more
10 Sep 2019 13:47

Nuformix Chief Financial Officer Kirk Siderman-Wolter Resigns Abruptly

(Alliance News) - Pharmaceutical company Nuformix PLC on Tuesday said Chief Financial Officer and Senior Independent Non-Executive Director Kirk Siderman-Wolter has resigned with immediate company

Read more
9 Sep 2019 11:25

Nuformix, Ebers Tech File Patent For Cannabinoid Cocrystals

(Alliance News) - Pharmaceutical company Nuformix PLC on Monday said it and partner Ebers Tech Inc have filed the first patent in relation to cannabinoid cocrystals.The patented cannabinoid

Read more
6 Sep 2019 12:17

Nuformix Hires Cambridge Interstitial Lung Disease Unit Lead Clinician

(Alliance News) - Nuformix PLC said on Friday it has appointed Muhunthan Thillai to its scientific advisory board with immediate effect.Thillai is the lead clinician for the Cambridge Lung

Read more
18 Jul 2019 11:16

Nuformix Annual Loss Narrows As Revenue Jumps On NXP001 Progress

(Alliance News) - Nuformix PLC on Thursday said its revenue multiplied in its most recently-ended financial year as it has secured its first licensing income from NXP001.NXP001 is one of in

Read more
30 May 2019 10:33

WINNERS & LOSERS SUMMARY: De La Rue Down As CEO Exits And Profit Falls

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - LOSERS----------National a

Read more
30 May 2019 10:14

Nuformix Shares Jump On Positive NXP001 Clinical Study Results

LONDON (Alliance News) - Shares in Nuformix PLC surged on Thursday as the company reported positive results in its clinical study of NXP001.Nuformix shares were trading 30% higher at 13.50

Read more
9 Apr 2019 11:25

Nuformix inks cannabinoid therapeutics deal with Ebers Tech

(Sharecast News) - Pharmaceutical development company Nuformix has inked an agreement for cannabinoid therapeutics development, licensing and commercialisation with Canadian outfit Ebers Tech.

Read more
9 Apr 2019 10:46

WINNERS & LOSERS SUMMARY: 7digital Warns Of Need For Capital Raise

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - WINNERS----------Anglo up -

Read more
22 Mar 2019 08:50

Nuformix Doses First Patient In NXP001 Anti-Nausea Drug Trial

LONDON (Alliance News) - Nuformix PLC on Friday said it has begun clinical studies for its anti-nausea drug NXP001 and dosed its first patient.Shares in Nuformix were down 4.6% at 2.10 on a

Read more
27 Feb 2019 10:48

MHRA gives go-ahead to Nuformix for human studies

(Sharecast News) - Pharmaceutical development company Nuformix has received approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) to begin human pharmacokinetics studies for its lead asset, NXP001, it announced on Wednesday.

Read more
3 Dec 2018 09:53

Nuformix Reports Positive Results From NXP002 Pre-Clinical Trial

LONDON (Alliance News) - Pharmaceutical development firm Nuformix PLC on Monday reported positive results from its completed NXP002 fibrosis programme pre-clinical trial for the treatment of a of

Read more
27 Nov 2018 10:04

Nuformix Expands NXP001 Agreement With Additional Pre-Clinical Study

LONDON (Alliance News) - Pharmaceutical development firm Nuformix PLC said on Tuesday it has expanded its current licensing agreement with partner Newsummit Biopharma for the development of cancer

Read more
14 Sep 2018 10:17

Nuformix Rises As NXP001 Passes "Major" Pre-Clinical Milestone

LONDON (Alliance News) - Shares in pharmaceutical firm Nuformix PLC rose Friday it has received a GBP500,000 payment after its NXP001 product reached a pre-clinical milestone.Nuformix was a

Read more
12 Sep 2018 16:00

UK Shareholder Meetings Calendar - Next 7 Days

Thursday 13 SeptemberBahamas PetroleumFlybe GroupBetter Capital PCCWorldwide 14 UK 17

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.